CanSino's #COVID_19 #vaccine candidate approved for military use in China
![]() 2474 Monday, 29 June, 2020, 17:25 China's military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and somewhat efficient, the company said on Monday. The Ad5-nCoV is one of the eight vaccine candidates being developed by Chinese companies and researchers approved to be moved into human trials for the respiratory disease caused by the new coronavirus. The shot also won approval for human testing in Canada. China’s Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year, CanSino said in a filing. The vaccine candidate was developed jointly by CanSino and the Beijing Institute of Biotechnology in the Academy of Military Medical Sciences. “The Ad5-nCoV is currently limited to military use only and its use cannot be expanded to a broader vaccination range without the approval of the Logistics Support Department,” CanSino said, referring to the Central Military Commission department where the military use of the vaccine was approved. |
Apple debuts iPhone 17
350Yesterday, 23:08Yuri Ivashechkin, the creator of the Su-25 attack aircraft, has died
109003.09.2025, 13:33Türkiye to build spaceport in Somalia for rocket, missile tests
289905.08.2025, 18:17A woman in India has been diagnosed with a unique blood type
379830.07.2025, 14:21Global media forum with Aliyev's participation to be held in occupied Stepanakert
467619.07.2025, 17:30SpaceX Starship rocket explodes during test flight (video)
688319.06.2025, 12:34Elon Musk announces XChat feature
771902.06.2025, 13:04The world's lowest car has been created in Taiwan (video)
918326.05.2025, 11:40